Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 85 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 8119618

    Compositions and methods for the treatment of inflammatory diseases

    The Board of Regents of the University of Oklahoma · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted

  2. US 8114590

    Diagnosis and treatment of chronic lymphocytic leukemia (CLL)

    The Regents of the University of California · Granted Feb 14, 2012 · Expires Feb 9, 2032

    granted

  3. US 8110553

    Methods and compositions for the treatment of gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted

  4. US 8110681

    Compounds for the treatment of spinal muscular atrophy and other uses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted

  5. US 8105607

    Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

    The Regents of the University of California · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted

  6. US 8101579

    Methods and compositions for the treatment of gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted

  7. US 8097606

    Antiglucocorticoids for the treatment of catatonia

    Corcept Therapeutics Incorporated · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted

  8. US 8093286

    Methods for treatment with bucindolol based on genetic targeting

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted

  9. US 8092838

    Use of hydrogen sulfide in the treatment of eye diseases

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted

  10. US 8088935

    Compounds and methods for the treatment of asthma

    IRONWOOD PHARMACEUTICALS, INC. · Granted Jan 3, 2012 · Expires Dec 29, 2031

    granted

  11. US 8088787

    Methods related to the treatment of neurodegenerative and inflammatory conditions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 3, 2012 · Expires Dec 29, 2031

    granted

  12. US 8084415

    Uteroglobin in the treatment of IGA mediated nephropathy

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  13. US 8080578

    Methods for treatment with bucindolol based on genetic targeting

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  14. US 8080241

    Viruses for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  15. US 8080526

    Methods and compositions for the treatment of gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  16. US 8080579

    Compositions and methods for treatment of inflammatory bowel disease

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  17. US 8080527

    Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection

    The Regents of the University of California · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  18. US 8075881

    Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure

    Regents of the University of Minnesota · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  19. US 8076304

    Methods and compositions for the diagnosis and treatment of cyclin A-1 associated conditions

    The Regents of the University of Colorado · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  20. US 8076352

    Administration of carboline derivatives useful in the treatment of cancer and other diseases

    PTC THERAPEUTICS, INC. · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  21. US 8071137

    Method for treatment of cartilage disorders with centella extract

    Advanced Technologies and Regenerative Medicine, LLC · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  22. US 8071087

    Reovirus for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  23. US 8067416

    Methods and compositions for the treatment of metabolic disorders

    BIOMARIN PHARMACEUTICAL INC. · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

  24. US 8066985

    Reovirus for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.